JOHN KRAMER: Open Payments
NPI 1740255231 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$22,948 in 29 payments from 5 companies in 2025. Trend: 2023 $31,269 · 2024 $23,407 · 2025 $22,948
Consulting: $13,924Speaker / faculty: $5,838Travel & lodging: $2,099Food & beverage: $1,025Education: $63
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $11,806 |
| Genentech USA, Inc. | 8 | $5,238 |
| Novartis Pharmaceuticals Corporation | 8 | $4,441 |
| Alexion Pharmaceuticals, Inc. | 1 | $1,400 |
| Biogen, Inc. | 1 | $63 |
Products named: Ocrevus, KESIMPTA, ULTOMIRIS, TYSABRI.
Industry payments across TN — which companies pay providers there.
